Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-25

Clinical Trial Update: Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients [NA]

View source ↗

Summary

A clinical trial evaluating the palliative use of high-flow oxygen nasal cannula in end-of-life lung disease patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Sao Joao | Conditions: Lung Disease, Acute Respiratory Distress Syndrome | NA | Status: WITHDRAWN